Daiichi Sankyo
Karen Kopp, PhD, is an accomplished professional in the biopharmaceutical industry with extensive experience in marketing and market access. Currently serving as Director of US Marketing for Dato-DXd and Director of Oncology Market Access Marketing & Strategy at Daiichi Sankyo, Inc. since March 2018, Karen previously held the position of VP, Managed Markets Content Expert at Syneos Health Communications. With prior experience as a Managed Markets Content Strategist at inVentiv Health and project management roles at Percipient, LLC, and Matchstick, LLC, Karen has a strong background in developing value propositions, pricing strategies, and market access projects. Earlier career experience includes a Senior Engineer role at Becton Dickinson, where a customer centricity strategy was implemented. Educational qualifications include an MBA from Columbia Business School, a PhD in Materials Engineering from UC Santa Barbara, and a BSE in Materials Science and Engineering from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.